121 related articles for article (PubMed ID: 25857330)
1. Increased Turnover at Limiting O2 Concentrations by the Thr(387) → Ala Variant of HIF-Prolyl Hydroxylase PHD2.
Pektas S; Taabazuing CY; Knapp MJ
Biochemistry; 2015 May; 54(18):2851-7. PubMed ID: 25857330
[TBL] [Abstract][Full Text] [Related]
2. Investigating the contribution of the active site environment to the slow reaction of hypoxia-inducible factor prolyl hydroxylase domain 2 with oxygen.
Tarhonskaya H; Chowdhury R; Leung IK; Loik ND; McCullagh JS; Claridge TD; Schofield CJ; Flashman E
Biochem J; 2014 Nov; 463(3):363-72. PubMed ID: 25120187
[TBL] [Abstract][Full Text] [Related]
3. Substrate preference of the HIF-prolyl hydroxylase-2 (PHD2) and substrate-induced conformational change.
Pektas S; Knapp MJ
J Inorg Biochem; 2013 Sep; 126():55-60. PubMed ID: 23787140
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterization and mRNA expression of HIF-prolyl hydroxylase-2 (phd2) in hypoxia-sensing pathways from Megalobrama amblycephala.
Wang H; Huang C; Chen N; Zhu K; Chen B; Wang W; Wang H
Comp Biochem Physiol B Biochem Mol Biol; 2015 Aug; 186():28-35. PubMed ID: 25868626
[TBL] [Abstract][Full Text] [Related]
5. Inverse solvent isotope effects demonstrate slow aquo release from hypoxia inducible factor-prolyl hydroxylase (PHD2).
Flagg SC; Giri N; Pektas S; Maroney MJ; Knapp MJ
Biochemistry; 2012 Aug; 51(33):6654-66. PubMed ID: 22747465
[TBL] [Abstract][Full Text] [Related]
6. Kinetic characterization and identification of a novel inhibitor of hypoxia-inducible factor prolyl hydroxylase 2 using a time-resolved fluorescence resonance energy transfer-based assay technology.
Dao JH; Kurzeja RJ; Morachis JM; Veith H; Lewis J; Yu V; Tegley CM; Tagari P
Anal Biochem; 2009 Jan; 384(2):213-23. PubMed ID: 18952043
[TBL] [Abstract][Full Text] [Related]
7. The second coordination sphere of FIH controls hydroxylation.
Saban E; Chen YH; Hangasky JA; Taabazuing CY; Holmes BE; Knapp MJ
Biochemistry; 2011 May; 50(21):4733-40. PubMed ID: 21456582
[TBL] [Abstract][Full Text] [Related]
8. Prolyl hydroxylase domain 2 protein suppresses hypoxia-induced endothelial cell proliferation.
Takeda K; Fong GH
Hypertension; 2007 Jan; 49(1):178-84. PubMed ID: 17101841
[TBL] [Abstract][Full Text] [Related]
9. A hidden aggregation-prone structure in the heart of hypoxia inducible factor prolyl hydroxylase.
Hadi-Alijanvand H; Proctor EA; Ding F; Dokholyan NV; Moosavi-Movahedi AA
Proteins; 2016 May; 84(5):611-23. PubMed ID: 26868435
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases.
Marxsen JH; Stengel P; Doege K; Heikkinen P; Jokilehto T; Wagner T; Jelkmann W; Jaakkola P; Metzen E
Biochem J; 2004 Aug; 381(Pt 3):761-7. PubMed ID: 15104534
[TBL] [Abstract][Full Text] [Related]
11. Oxidative Dimerization of PHD2 is Responsible for its Inactivation and Contributes to Metabolic Reprogramming via HIF-1α Activation.
Lee G; Won HS; Lee YM; Choi JW; Oh TI; Jang JH; Choi DK; Lim BO; Kim YJ; Park JW; Puigserver P; Lim JH
Sci Rep; 2016 Jan; 6():18928. PubMed ID: 26740011
[TBL] [Abstract][Full Text] [Related]
12. Substrate positioning by Gln(239) stimulates turnover in factor inhibiting HIF, an αKG-dependent hydroxylase.
Hangasky JA; Ivison GT; Knapp MJ
Biochemistry; 2014 Sep; 53(36):5750-8. PubMed ID: 25119663
[TBL] [Abstract][Full Text] [Related]
13. Gas tunnel engineering of prolyl hydroxylase reprograms hypoxia signaling in cells.
Windsor P; Ouyang H; da Costa JAG; Damodaran AR; Chen Y; Bhagi-Damodaran A
bioRxiv; 2024 May; ():. PubMed ID: 37609209
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of angiogenesis through stabilization of hypoxia-inducible factor-1 by silencing prolyl hydroxylase domain-2 gene.
Wu S; Nishiyama N; Kano MR; Morishita Y; Miyazono K; Itaka K; Chung UI; Kataoka K
Mol Ther; 2008 Jul; 16(7):1227-34. PubMed ID: 18500250
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the catalytic activity of hypoxia-inducible factor-1alpha-prolyl-hydroxylase 2 by a MYND-type zinc finger.
Choi KO; Lee T; Lee N; Kim JH; Yang EG; Yoon JM; Kim JH; Lee TG; Park H
Mol Pharmacol; 2005 Dec; 68(6):1803-9. PubMed ID: 16155211
[TBL] [Abstract][Full Text] [Related]
16. Oxygen sensing by the prolyl-4-hydroxylase PHD2 within the nuclear compartment and the influence of compartmentalisation on HIF-1 signalling.
Pientka FK; Hu J; Schindler SG; Brix B; Thiel A; Jöhren O; Fandrey J; Berchner-Pfannschmidt U; Depping R
J Cell Sci; 2012 Nov; 125(Pt 21):5168-76. PubMed ID: 22946054
[TBL] [Abstract][Full Text] [Related]
17. Computational analysis of prolyl hydroxylase domain-containing protein 2 (PHD2) mutations promoting polycythemia insurgence in humans.
Minervini G; Quaglia F; Tosatto SC
Sci Rep; 2016 Jan; 6():18716. PubMed ID: 26754054
[TBL] [Abstract][Full Text] [Related]
18. Time-dependent inhibition of PHD2.
Tcholakov I; Grimshaw CE; Shi L; Kiryanov A; Murphy ST; Larson CJ; Plonowski A; Ermolieff J
Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28592559
[TBL] [Abstract][Full Text] [Related]
19. Significance of prolyl hydroxylase 2 in the interference of aryl hydrocarbon receptor and hypoxia-inducible factor-1 alpha signaling.
Seifert A; Katschinski DM; Tonack S; Fischer B; Navarrete Santos A
Chem Res Toxicol; 2008 Feb; 21(2):341-8. PubMed ID: 18072750
[TBL] [Abstract][Full Text] [Related]
20. Conditional Deletion of Prolyl Hydroxylase Domain-Containing Protein 2 (Phd2) Gene Reveals Its Essential Role in Chondrocyte Function and Endochondral Bone Formation.
Cheng S; Xing W; Pourteymoor S; Schulte J; Mohan S
Endocrinology; 2016 Jan; 157(1):127-40. PubMed ID: 26562260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
